4 ms·
IIRC yes but they were relegated to academic study. Something being successful on the market is a huge catalyst for other pharma companies to invest on the tech
by kevinsundar 5y ago
IIRC yes but they were relegated to academic study. Something being successful on the market is a huge catalyst for other pharma companies to invest on the tech.
- Denvercoder9 5y agoThe vaccine community was already well aware of the potential of mRNA vaccines, it just needed a bit more development to mature. The pandemic provided that final push, but without the pandemic that would still have happened, just at a lower pace. They'd still be available and successful on the market in 2025 or so.